GIFT Nifty Hits All-Time Volume and Open Interest Records in Single Session
GIFT Nifty recorded 457,999 contracts worth $21.18 billion on September 24, 2026, as open interest hit an all-time high signaling institutional accumulation.
TLDR
- โGIFT Nifty recorded 457,999 contracts worth $21.18B on Sept 24 โ an all-time volume record
- โOpen interest also hit a record high, signaling fresh institutional position-building not just rollovers
- โDual record reinforces GIFT City as Asia's fastest-growing derivatives hub, pressuring SGX India products
Editorial Self-Reviewยท82/100Publish tier
- Specific volume and value figures from a T1 source
- Clear India/Asia relevance with institutional implications
- Forward-looking signals tied to concrete data releases
- Single source limits cross-verification of record claim
Why this matters
Coverage sentiment: Bullish (1 bullish ยท 0 neutral ยท 0 bearish)
GIFT Nifty's record volume directly concerns India equity investors as it signals surging offshore institutional interest, potentially amplifying expiry-week volatility for domestic NSE participants.
What to watch
- โข GIFT Nifty monthly expiry data โ whether record open interest unwinds smoothly or triggers volatility spikes
- โข RBI policy meeting โ hawkish signals could reverse FPI positioning and deflate GIFT Nifty activity rapidly
Ripple effects
- โข NSE domestic index derivatives โ record GIFT OI may amplify expiry-week spot swings for Nifty 50 and Bank Nifty
AI-Synthesized news from multiple sources
This article was synthesized by AI from the source articles listed below, reviewed by a second-pass AI quality reviewer, and published by the market.news editorial system. How we do this ยท Editorial standards ยท Report an error
The Quick Take
- GIFT Nifty recorded 457,999 contracts worth $21.18 billion in a single trading session on September 24, 2026
- Open interest simultaneously reached an all-time high, signaling sustained institutional position-building
- The dual records mark a milestone in GIFT City's emergence as Asia's fastest-growing derivatives hub
GIFT Nifty, the GIFT City-based offshore derivative on India's benchmark index, logged its highest ever single-day trading volume on September 24, 2026, with 457,999 contracts exchanged worth $21.18 billion. Simultaneously, open interest reached an all-time high, suggesting fresh positions are being built rather than existing ones rolled over. This dual record places GIFT City prominently among Asia's fastest-growing international financial centres, underscoring India's push to repatriate offshore rupee-denominated derivatives activity previously routed through Singapore and Dubai.
โThe record volumes indicate deepening offshore institutional engagement with Indian equity markets.โ
The record volumes indicate deepening offshore institutional engagement with Indian equity markets. Foreign portfolio investors, hedge funds, and global asset managers increasing GIFT Nifty positions signals rising confidence in India's near-term equity trajectory. Peers such as SGX Nifty products and derivatives on Korea's KOSPI or Hong Kong's HSI face intensifying competition as GIFT City's liquidity profile strengthens, while elevated open interest raises the significance of monthly roll-over windows for domestic NSE volatility dynamics.
Watch for monthly derivatives expiry data from the NSE to determine whether GIFT Nifty's record open interest translates into elevated spot volatility. The critical macro variable is RBI policy direction โ rising rate expectations noted in concurrent market commentary could cap equity upside and prompt position unwinding. Regulatory developments around GIFT City's banking and insurance infrastructure could further attract global capital, compounding derivatives growth into Q4 2026.
Synthesized from 1 source.
Market Intelligence Panel
Sentiment
BullishCoverage
livesource covering this story
Live Price
NSE:NIFTY๐ India / Asia Angle
GIFT Nifty's record volume directly concerns India equity investors as it signals surging offshore institutional interest, potentially amplifying expiry-week volatility for domestic NSE participants.
๐ Ripple Effects
- โธNSE domestic index derivatives โ record GIFT OI may amplify expiry-week spot swings for Nifty 50 and Bank Nifty
- โธSingapore Exchange (SGX) โ continued migration of offshore India derivatives volume to GIFT City erodes SGX fee base
- โธIndia-focused ETFs and FPIs โ record participation signals bullish tilt toward Indian equities, sustaining FII inflows
๐ญ What to Watch Next
PRO- โธGIFT Nifty monthly expiry data โ whether record open interest unwinds smoothly or triggers volatility spikes
- โธRBI policy meeting โ hawkish signals could reverse FPI positioning and deflate GIFT Nifty activity rapidly
- โธGIFT City banking license announcements โ expanded financial services would attract more global participants
Market news synthesis. Not financial advice. Sources cited above.
How the Story Spread
1 publisher covering this story
AI synthesis of every source listed below. Tier 1 = wire services (AP, Reuters via wire, Bloomberg, official central banks). Tier 2 = major financial publishers. Tier 3 = niche / specialist outlets. Click any card to read the original article.
Get the Daily Briefing
Pre-market analysis every morning at 6am ET. Free.
Was this article useful?
Anonymous ยท helps us tune the editorial system
More ๐ฎ๐ณ India Stories
PGIM India: Rate-Cut Cycle Over, RBI May Hike 50-75 bps by FY27 on Sticky Inflation
PGIM India's Puneet Pal forecasts India's rate-cut cycle is over, projecting the RBI will hike 50-75 bps by FY27 as crude prices rise and inflation stays sticky.
Sep 26, 2026
๐ฎ๐ณ IndiaGST Council Meets October 7: No Rate Changes Expected, MDR Levy and Process Reforms in Focus
India's GST Council convenes October 7 with no broad rate changes expected โ focus is on process reforms and a potential review of the 18% GST on Merchant Discount Rate (MDR) for digital payments.
Sep 26, 2026
๐ฎ๐ณ IndiaBiocon Malaysia Arm Gets UK MHRA Approval for Semglee Insulin Fill-Finish Unit
Biocon's Malaysia fill-finish unit received UK MHRA approval for Semglee insulin, following EMA clearances โ completing the dual European regulatory framework for Biocon's biosimilar manufacturing hub.
Sep 26, 2026